A Review on the Status of Breast Cancer Care in Tanzania

Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 173

This Paper With 10 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

این Paper در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_MCIJO-4-3_001

تاریخ نمایه سازی: 15 بهمن 1399

Abstract:

Tanzania continues to enjoy stability and growth in different sectors similar to other countries; however, some challenges persist in the health sector, especially in the area of cancer care. The current study aimed at reviewing social economic status (SES), as well as factors contributing to the increased burden of breast cancer (BC) in Tanzania. The current study reviewed different articles and literature from nationally/internationally published statistics, academic publications, health information of non-governmental organizations, academic researchers, and other sources of health information  to better understand the socioeconomic and BC care status in Tanzania. The current review results showed that BC is still the second most prevalent malignant disease in Tanzania, and most of the patients referring to medical centers are in the advanced stage of the disease due to shortage and unaffordability of health care services. The majority of health-related interventions and investments target infectious diseases,including HIV, tuberculosis, malaria, as well as maternal and child health-relatedconditions, compared to noncommunicable diseases (NCDs) such as BC. In spite of some setbacks and improvements in healthcare facilities (e g, novel techniques for early detection), the best way to address BC care is affordable fees for clinical and laboratory investigations, accessible treatment, palliative care, follow-up, rehabilitative care, and better management and allocation of resources.

Authors

Hidaya Mansouri

Department of Global Health and Bio-Medical Sciences (GHBM), Nelson Man- dela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania

Amos R. Mwakigonja

Department of Pathology, Muhimbili University of Health and Allied Sciences (MUHAS), Dar es Salaam, Tanzania

Faith A. Rodgers,

Department of Economics, College of Social Sciences (COSS), University of Dar es Salaam, Dar es Salaam, Tanzania

Emmanuel A. Mpolya

Department of Global Health and Bio-Medical Sciences (GHBM), Nelson Man- dela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania

Sauli Elingarami

Department of Global Health and Bio-Medical Sciences (GHBM), Nelson Man- dela African Institution of Science and Technology (NM-AIST), Arusha, Tanzania

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • 1. Deloitte Touche Tohmatsu Limited. Tanzania Economic Outlook 2016. The Story ...
  • 2. National Bureau of Statistics, Ministry of Finance, Office of Chief ...
  • 3. Economic and Social Research Foundation, United Na- tions Development Programme, ...
  • 4. Leliveld A, Dietz T, Klaver W, Kilama B, Foeken ...
  • 5. Piot P, Caldwell A, Lamptey P, Nyrirenda M, Mehra S, ...
  • 6. World Bank, UNICEF, UNFPA. Health Systems for the Millennium Development ...
  • 7. Elingarami S. Cancer: Incidence, Molecular Biology and Future Research Direction. ...
  • 8. Shayo FK. Co-occurrence of risk factors for non-commu- nicable diseases ...
  • 9. Mayige M, Kagaruki G, Ramaiya K, Swai A. Non com- ...
  • 10. Roman WP, Martin HD, Sauli E. Assessment of risk factors ...
  • 11. African Health Observatory (AHO), World Health Organi- zation (WHO). Factsheet ...
  • 12. Government of the United Republic of Tanzania, Unit- ed Nations ...
  • 13. Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, ...
  • 14. Alwan A, Armstrong T, Bettcher D, Branca F, Chisholm D, ...
  • 15. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, ...
  • 16. Mabula JB, McHembe MD, Chalya PL, Giiti G, Chandi- ka ...
  • 17. World Health Organization. Noncommunicable diseases country profiles 2014 Geneva, Switzerland: ...
  • 18. World Health Organization. Noncommunicable diseases country profiles 2018 Geneva, Switzerland: ...
  • 19. Sasco AJ. Epidemiology of breast cancer: an environ- mental disease? ...
  • 20. Castello A, Martin M, Ruiz A, Casas AM, Baena-Cana- da ...
  • 21. Hamajima N, Hirose K, Tajima K, Rohan T, Calle EE, ...
  • 22. World Health Organization. United Republic of Tanzania: WHO Country Cooperation ...
  • 23. Jemal A, Bray F, Center MM, Ferlay J, Ward E, ...
  • 24. Jones SA. Global burden of Non Communicable Diseases. Aust Nurs ...
  • 25. Latest global cancer data [press release]. Lyon, France: International Agency ...
  • 26. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, ...
  • 27. World Health Organization. Cancer Geneva, Switzerland: World Health Organization; 2018 ...
  • 28. Ministry of Health, Community Development, Gender, Elderly and Children. National ...
  • 29. Rambau P, Masalu N, Jackson K, Chalya P, Serra P, ...
  • 30. Burson AM, Soliman AS, Ngoma TA, Mwaiselage J, Og- weyo ...
  • 31. Mbonde MP, Amir H, Akslen LA, Kitinya JN. Expression of ...
  • 32. Ministry of Health, Community Development, Gender, Elderly and Children. Tanzania ...
  • 33. Mwakigonja AR, Lushina NE, Mwanga A. Characteriza- tion of ...
  • 34. Black E, Richmond R. Improving early detection of breast cancer ...
  • 35. Mansouri H, Mnango LF, Magorosa EP, Sauli E, Mpolya EA. ...
  • 36. American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta: ...
  • 37. Eble JN, Tavassoli FA, Devilee P. Pathology and Genetics of ...
  • 38. Allen J, Burrell C, Caplice C, Collins D, McGreal P, ...
  • 39. Silverberg SG. Atlas of Breast Pathology. Philadelphia: W.B. Saunders; 2002. ...
  • 40. National Comprehensive Cancer Network. NCCN Clini- cal Practice Guidelines in ...
  • 41. Shapochka DO ZS, Gnidyuk MI Expression of Molecular Markers in ...
  • 42. Strand C, Bak M, Borgquist S, Chebil G, Falck A-K, ...
  • 43. Zaha DC. Significance of immunohistochemistry in breast cancer. World J ...
  • 44. Dumay A, Feugeas JP, Wittmer E, Lehmann-Che J, Bertheau P, ...
  • 45. Gasco M, Shami S, Crook T. The p53 pathway in ...
  • 46. Hwang KT, Han W, Kim J, Moon HG, Oh S, ...
  • 47. Hwang K-T, Kim K, Chang JH, Oh S, Kim YA, ...
  • 48. Nalwoga H. Molcular Markers in Breast Carcinoma. A study with ...
  • 49. Kim T, Han W, Kim MK, Lee JW, Kim J, ...
  • 50. Li LT, Jiang G, Chen Q, Zheng JN. Ki67 is ...
  • 51. Mwakigonja AR, Rabiel H, Mbembati NA, Lema LE. The pattern ...
  • 52. Alwash Z, Henke O, Serventi F, Kantelhardt EJ. Staff Perspectives ...
  • 53. Rabinowitz B. Interdisciplinary breast cancer care: de-claring and improving ...
  • 54. Ogweyo PA. Feasibility and cost effectiveness of using fine needle ...
  • 55. Chalya PL, Lema MK, Mabula JB, Rambau P, McHem- be ...
  • 56. Pace LE, Shulman LN. Breast cancer in sub-Saharan Af- rica: ...
  • 57. Rambau PF, Chalya PL, Manyama MM, Jackson KJ. Pathological features ...
  • 58. World Health Organization. Assessing national capacity for the prevention and ...
  • 59. Silverstein A, Sood R, Costas-Chavarri A. Breast cancer in Africa: ...
  • 60. Kabel AM. Tumor markers of breast cancer: New pro- spectives. ...
  • 61. Bravaccini S, Ravaioli S, Amadori D, Scarpi E, Puccetti M, ...
  • 62. Pfefferle AD, Agrawal YN, Koboldt DC, Kanchi KL, Herschkowitz JI, ...
  • نمایش کامل مراجع